Materials and Methods: Patients who had 1-2 cm kidney stones in the lower pole calyces whose calyceal necks (length: <10 cm, and width: > 5mm), pelvicalyceal angle (>30o) and relatively shorter stone-skin distance as determined based on tomographic urography results were included in the study. Patients with renal cystine, whewellite stones or stones with a hardness above 1000 Hounsfield units were excluded. The groups were not formed randomly. Contarily, treatment methods were explained to the patients and let them decide the treatment method for themselves. Each group consisted of 34 patients.
Results: After excluding nine patients who were lost to follow-up, the study was completed with 93 patients at the final analysis. Stone-free rate was lower in Group A (47%) than Groups B (80.5%) and C (77%) (p<0.001). The mean number of sessions was 2.1 for Group A, 1.55 for Group B and 1 for Group C (p<0.001). Average procedure costs were $169, $1427, and $947 for Groups A, B, and C, respectively (p<0.001). Median length of hospital stay for Groups A, B, and C was 1, 20, and 48 hours (p<0.001), respectively, and 2, 3.9 and 5.5 working days were lost, respectively (p<0.001).
Conclusion: RIRS and micro-PNL had more stone-free rate, but number of working days were lost with lower medical expenditures in the SWL group. The priority of the patients should be determined, and the choice of treatment should be decided in collaboration with them.
Many urologists choose SWL as a low-morbidity outpatient option, and many patients tolerate it. PNL is recommended as the primary choice by the European Association of Urology (EAU) for stones bigger than 2 cm and SWL or RIRS for stones smaller than 1 cm. However, the optimal treatment choice for mediumsized lower pole calyceal stones measuring 1 to 2 cm is still up for debate [4]. Furthermore, it is known that SWL is linked to insufficient fragment clearance from the lower pole [5].
Because it has a high success rate regardless of stone size, PNL is currently the standard treatment of choice for large stones (> 2 cm) and is also preferred by many urologists for the treatment of multiple renal stones or stones in the dependent parts of the kidney, such as the lower pole. However, the substantial risk of morbidity outweighs the advantage of high stone-free rate [6]. Miniaturized PNLs with smaller nephroscopes can reduce surgical morbidity. In the removal of renal stones, its efficiency is comparable to that of normal PNL. Miniaturized nephroscopes have calibers ranging from 4.8 to 22 F, with mini- PNL (14-22 F), ultramini-PNL (13 F), and micro-PNL (4.8 F) being the most used ones [7].
Flexible ureteroscopy, which was originally used to treat lower pole calyceal stones that were resistant to SWL, may be a less intrusive option to percutaneous treatments [8]. RIRS is becoming more popular as a main treatment for these stones, with greater stone-free rates than SWL and lower patient morbidity than PNL.
Medical expenditures for treating stone disease involve direct and indirect costs. All medical expenses (e.g., prescriptions, hospitalization charges, all consumables and non-consumables required during surgery) are considered direct costs, whereas indirect costs include the patient's lost working days [9]. Healthcare systems and individuals nowadays desire shorter hospital stays, speedier return to work, maximum cost efficiency, and higher surgical success rates [10,11].
We compared the safety, efficacy, and cost-effectiveness of SWL, RIRS, and micro-PNL in this study to determine an individualized management for 1-2-cm stones in the lower pole calyces.
All procedures were performed by the same surgical team. The urologist who performed the operations was experienced in all these procedures. All patients" urine cultures were sterile before operation. The stone surface was calculated using the formula: height x width x 0.25 x π).
Informed, written consent was obtained from all patients. Ethical approval was granted by University of Health Sciences Sancaktepe Training and Research Hospital Ethics Committee (date: 27.01.2021; decision #: 88).
Surgical Procedure
The endoscopic instruments used had a caliber of 4.8 Fr for
micro-PNL (PolyDiagnost, Pfaffenhofen, Germany). Flexible
cystoscopes or ureteroscopes were not used, and only a laser
lithotripsy was employed in micro-PNL (Figure 1). Nephrostomy
tubes were not inserted in any patient who underwent micro-PNL. A
double-J ureteral stent was placed when required in the presence of
pelvic perforation, residual stone, and intraureteral stone migration.
For RIRS, diagnostic ureteroscopy was performed with a semi-rigid
6/7.5 Fr ureteroscope (Richard Wolf, Knittlingen, Germany). A 7.5
Fr flexible ureteroscope (Flex X2, Karl Storz, Tuttlingen, Germany)
was utilized for the primary operation. A holmium: YAG laser was
used to fragment the stones down to the size of 272 microns. The
stones were dusted rather than removed using a basket or other
equipment. For SWL therapy, an Argemet A1000 device (Turkey)
was employed at a frequency of 90 shocks per minute. The starting
voltage for SWL was 14 kV for 500 SWs, then raised in 2 kV
increments every 500 shock waves (SWs) until stone fragmentation
started, or up to a maximum value of 24 kV. Stone disintegration was
confirmed both by the SWL operator and the surgeon in charge by
radiographic control.
Figure 1. Micro-PNL surgical equipment
The cost of procedure per case included the money spent to purchase disposable materials (e.g., guide, urethral catheter, cover set, gloves), special materials (access sheath for RIRS, dilator set for micro-PNL), drugs (e.g., antibiotics, IV fluids for replacement, analgesics), in addition to hospitalization cost per day, and fees charged for stent removal and endoscopy. The daily bed cost (approximately 20 USD) is standard for patients operated on in Turkey. The daily bed cost in the National Health Care System of Turkey is approximately 10% of the monthly minimum wage and was calculated as a reference guide for other physicians who are working in different health insurance systems. The average costs of the instruments used per procedure were calculated using the data obtained from the relevant records of the previous five years. Instrument costs encompass money spent for purchase and repair of the instrument. The case number of lifetime cycles were 70 for micro-PNL and 35 for flexible ureteroscope. Total costs include the costs of the procedure plus the mean cost of endoscopy per case. The Argemet A1000 SWL device (Turkey) has a 200-case maintenance cycle, and the maintenance fee is $3000.
Outcome Assessment
The primary outcome measures were the stone-free rate and
cost, while the time to return to daily activities and length of
hospital stay were the secondary outcome measures. Since SWL
was conducted in an outpatient environment, hospitalization was
measured by the number of hours spent in the hospital. Every
SWL session lasted at least one hour, including premedication.
The time to return to daily activities was determined by patient
self-report. Daily life activity was defined as the patient being
able to work at full capacity at the same level as preoperatively,
without moderate or severe pain and limitation of movement. In
addition, the total period elapsed till return to daily life activities
increased by the number of working days lost owing to severe
lower urinary tract symptoms before starting to work. Operative
time was not assessed because SWL was not performed under
anesthesia in an operation room and fluoroscopy time was
assessed instead. Stone-free status was defined as lack of any
residual stone or a clinically insignificant 3 mm- residual stone
on non-contrast computed tomographic examination performed
three months following the last procedure. Secondary procedures
involved a semi-rigid ureteroscopy performed for ureter stones. Clavien-Dindo classification was used to categorize the
complications. Clavien-Dindo grade ≥ 2 complications were
included in the statistical analysis.
Statistical Analysis
The mean age, body-mass index (BMI), stone surface area,
fluoroscopy time, length of hospital stay, time to return to
normal daily activities, treatment cost, stone-free rate (SFR),
and complication rates were compared between groups.
Statistical analysis showed that the patients in each treatment
group were normally distributed, with a standard deviation of
10. The expected true difference in the success rate of surgery
was 10%. The type I error probability associated with this null
hypothesis test was 0.05. To reject the null hypothesis that the
surgical success rates of the two groups were the same, we needed
to investigate 30 individuals in each group with a probability of
0.8. The estimated rate of patient loss to follow-up was 10%. All
participants were stratified by computer-generated pseudorandom
numbers according to surgical procedures. The Statistical Package
for the Social Sciences (SPSS, Chicago, IL, USA) version 17 for
Windows was used for statistical analysis. To compare groups,
one-tailed ANOVA and Pearson chi-square tests were performed.
A Tukey test was used for post-hoc analysis. Level of statistical
significance was defined as a p value of less than 0.05.
Table 1. The detail of the groups
Table 2. Outcomes of the procedures
Median hospital stay was shorter in Group A (1 hour) than in Groups B (20 hours) and C (48 hours) (p<0.001). Each SWL session lasted one hour, including premedication. Thus, the minimum hospitalization time was one hour in the SWL group. In the SWL group, three patients were hospitalized for seven, and three patients for one day. Subcapsular hematomas developed in two patients hospitalized for seven days were resolved with only bed rest. One patient was hospitalized for three days because of fever, and three patients were interned for one day due to renal colic unresponsive to medication. Hence, the maximum hospital stay was 168 hours (7 days) in Group A. Patients who underwent RIRS and micro-PNL were routinely discharged the next day. However, some of them had longer hospitalization periods due to the presence of pain, fever, gross hematuria, and sepsis. Thus, the maximum hospital stays were 144 hours (6 days) in the micro-PNL and 192 hours (8 days) in the RIRS group. Sepsis occurred in two patients in the RIRS group, and gross hematuria in one patient in the micro-PNL group.
The mean number of sessions was 2.1 in Group A, 1.55 in Group B, and 1 in Group C (p<0.001). The mean number of working days lost was lower in Group A (2 days) than in Groups B (3.9 days) and C (5.5 days) (p<0.001). In the SWL group, the total working time lost was calculated as four hours (half of a working day), including time spent for coming to the hospital, evaluation, and treatment processes, and return to work or home.
In other words, each SWL session means a loss of half a working day. The mean number of sessions was 2.1 in the SWL group, so the mean number of working days lost should have been about one day, but it increased to two days due to complications developed in patients. In the RIRS group, removal of a double-j stent resulted in loss of a working day as well as the need for a control or emergency visit in an extra session in more than half of the patients, and prolonged hospitalization due to complications, all of which increased the mean number of working days lost approximately four-fold. In the micro-PNL group, the median hospitalization time was two days, along with the half-day spent for the control visit resulted in an exact loss of 2.5 working days. However, we recommended bed rest for at least two days for our patients. Taking into account urinary tract infections, hematuria, and the prolonged hospitalization required for some patients, on an average, 5.5 working days were lost.
The mean cost of procedures was $169, $1427, and $947 for Groups A, B, and C, respectively (p<0.001). The cost of all materials used throughout the procedure was also documented (Table 3). These were the direct costs, that is, the money that the health system rather than the patients spent. Complication rates were similar between groups (Table 2). The most severe complication was sepsis, and none of the patients received blood transfusions or were transferred to the intensive care unit. Sepsis occurred in two patients, one in the SWL group and one in the RIRS group.
Table 3. Costs for each spend unit ($) (N.A.: Not applicable)
Because of the high recurrence rate and the possibility of reoperation after treatment of 1-2 cm stones in a lower pole calyx, a rational treatment approach that provides maximum SFR which is a key parameter in evaluating the efficacy of a stone management procedure with minimal morbidity is needed, [12]. Although SWL has been the preferred option for lower pole calyceal stones for many years, its low SFRs have prompted clinicians to seek alternatives. Because of the disadvantages of SWL for this group of stones, RIRS and PNL are now the preferred treatment options [13].
Based on the available literature data, the SFR for the first session of SWL is around 46-64% [14,15]. Similar to these data, our SFR was 47.7% which was statistically significantly lower compared to the other groups. The SFR of the first session of RIRS has been reported as approximately 60-65% [13,16]. In this study, it was 80.5%. The SFR for micro-PNL has been reported as 83% [17,18], while in our study it was 77%.
Post-procedural complications are among the main reasons for long hospital stays and delays in patients" return to daily life. Further, the cost of the procedures increases when complications occur [19]. The mean hospital stay for RIRS has been reported as 1-2 days, compared to 1.1-2.4 days for micro-PNL [11,17]. Usually, uncomplicated SWL is an outpatient procedure, but it may still result in the loss of a working day. Similar to literature, the mean hospital stay in our study was shorter in Group A (1 hour) than in Groups B (20 hours) and C (48 hours). Our results showed that the greater the degree of invasiveness, the longer the hospital stay. The daily hospital bed cost was $20, which is approximately 6% of the monthly minimum wage in Turkey. Although it is cheaper than in other countries, other hospital, and medical expenses are comparable because disposable materials and endoscopes are imported. This phenomenon may seem to be an advantage favoring invasive procedures in terms of direct costs. However, there are conflicting data in the literature regarding the length of time it takes a urolithiasis patient to return to daily activities. For example, Demirbas et al. [20] reported length of hospital stay as 11.26 days for ultra-mini PNL, while Xun et al., [21] indicated 5.76 days for standard PNL. In a study from Spain, although the direct costs of URS/RIRS were higher than those of ESWL, no statistically significant difference was found between them in terms of indirect costs [22]. We think that the length of hospital stay differs dependent on local conditions. In our clinic, we encouraged patients to return to daily activities as soon as possible. The mean number of working days lost for SWL (2 ± 3.7 days), RIRS (3.9 ± 2.5 days), and micro-PNL (5.5 ± 3.6 days) were as indicated (p<0.001). Although the highest average number of working days lost was detected in Group C, the number of working days lost was in the narrowest range in this group due to lower contingency. We cannot calculate a net amount of financial loss for a working day lost because each patient's daily earnings are different. However, if we accept that the daily earnings are similar for each patient group, we can say that the cost of the procedure increases in line with the degree of invasiveness of the treatment method used. The costs of each procedure may vary by country and by healthcare system [23]. There are few studies on the cost of SWL, but many studies report that the procedure cost was lower for patients with lower stone burden, decreased Hounsfield unit of stone density (<1000), and more favorable renal anatomy [3,24]. Perez et al. reported the direct cost of one session of ESWL as $1690.5 [22]. Regarding the other methods, the mean cost of RIRS in Germany is $951, while in England it is $1398. A miniaturized PCNL in Germany costs $562, while the same procedure in England costs $749 (11). In a Turkish study, the total medical expenditures for RIRS and micro-PNL were reported to be $1250 and $962, respectively [25]. In this study, the mean procedure costs were $169, $1427, and $947 for Groups A, B, and C, respectively. As mentioned before, our RIRS cost was higher than that of the micro-PNL procedure in consideration of the use of a routine access sheath and the insertion, and then removal of a double-j stent.
In summary, our study offered a detailed analysis of the safety, efficacy, and cost-effectiveness of these three procedures used for stone extraction. Like all medical problems, management of urinary stone disease imposes a significant socio-economic burden. Moreover, there are financial and social costs related to the working days lost, and the direct costs of the procedures may actually convey greater importance. On the other hand, failure both to determine the Hounsfield units of the stones and also to perfom stone analysis are potential limitations of the study.
Ethics Committee Approval: Ethical approval was granted by University of Health Sciences Sancaktepe Martyr Prof. Dr. Ilhan Varank Training and Research Hospital Ethics Committee (date: 27.01.2021; decision #: 88).
Informed Consent: An informed consent was obtained from all the patients.
Publication: The results of the study were not published in full or in part in form of abstracts.
Peer-review: Externally and internally peer-reviewed.
Authorship Contributions: Any contribution was not made by any individual not listed as an author. Concept - C.Y., M.Y.S.; Design - C.Y., M.Y.S.; Supervision - M.Y.S., A.Y.; Resources - M.Y.S., A.Y.; Materials - M.Y.S., A.Y.; Data Collection and/ or Processing - M.Y.S., A.Y.; Analysis and/or Interpretation - C.Y., G.B.; Literature Search - M.Y.S., A.Y.; Writing Manuscript - C.Y., M.Y.S.; Critical Review - C.Y., G.B.
Conflict of Interest: The authors declare that they have no conflicts of interest.
Financial Disclosure: The authors state that they have not received any funding.
1) Long LO, Park S. Update on nephrolithiasis management.
Minerva Urol Nefrol. 2007;59:317-25.
https://pubmed.ncbi.nlm.nih.gov/17912227/
2) Donaldson JF, Lardas M, Scrimgeour D, Stewart F, MacLennan
S, Lam TB, et al. Systematic review and meta-analysis of the
clinical effectiveness of shock wave lithotripsy, retrograde
intrarenal surgery, and percutaneous nephrolithotomy for
lower-pole renal stones. Eur Urol 2015;67:612-6.
https://doi.org/10.1016/j.eururo.2014.09.054
3) Raman JD, Pearle MS. Management options for lower pole
renal calculi. Curr Opin Urol 2008;18:214-9.
https://doi.org/10.1097/MOU.0b013e3282f517ea
4) C. Turk, A. Neisius, A. Petřík, C. Seitz, A. Skolarikos, B.
Somani, K. Thomas, G. Gambaro. Guidelines Associates: N.F.
Davis, J.F. Donaldson, R. Lombardo, L. Tzelves. European
Association of Urology guidelines on urolithiasis 2021.
https://uroweb.org/guideline/urolithiasis/
5) Sumino Y, Mimata H, Tasaki Y, Ohno H, Hoshino T,
Nomura T, et al. Predictors of lower pole renal stone
clearance after extracorporeal shock wave lithotripsy. J Urol
2002;168:1344-7.
https://doi.org/10.1016/S0022-5347(05)64445-X
6) Breda A, Ogunyemi O, Leppert JT, Schulam PG. Flexible
ureteroscopy and laser lithotripsy for multiple unilateral
intrarenal stones. Eur Urol 2009;55:1190-6.
https://doi.org/10.1016/j.eururo.2008.06.019
7) Ruhayel Y, Tepeler A, Dabestani S, MacLennan S, Petřík
A, Sarica K, et al. Tract Sizes in Miniaturized Percutaneous
Nephrolithotomy: A Systematic Review from the European
Association of Urology Urolithiasis Guidelines Panel. Eur
Urol 2017;72:220-35.
https://doi.org/10.1016/j.eururo.2017.01.046
8) Grasso M, Ficazzola M. Retrograde ureteropyeloscopy for
lower pole caliceal calculi. J Urol 1999;162:1904-8.
https://doi.org/10.1016/S0022-5347(05)68065-2
9) Boccuzzi SJ. Indirect Health Care Costs. In: Weintraub W.S.
(ed) Cardiovascular Health Care Economics. Contemporary
Cardiology pp. 2003;63-79. Totowa, NJ, Humana Press.
https://link.springer.com/chapter/10.1007/978-1-59259-39 8-9_5
10) Pan J, Chen Q, Xue W, Chen Y, Xia L, Chen H, et al. RIRS
versus mPCNL for single renal stone of 2-3 cm: clinical
outcome and cost-effective analysis in Chinese medical
setting. Urolithiasis 2013;41:73-8.
https://doi.org/10.1007/s00240-012-0533-8
11) Schoenthaler M, Wilhelm K, Hein S, Adams F, Schlager
D, Wetterauer U, et al. Ultra-mini PCNL versus flexible
ureteroscopy: a matched analysis of treatment costs
(endoscopes and disposables) in patients with renal stones
10-20 mm. World J Urol 2015;33:1601-5.
https://doi.org/10.1007/s00345-015-1489-4
12) Klein J, Netsch C, Sievert KD, Miernik A, Westphal J, Leyh
H, et al. Extracorporeal shock wave lithotripsy. Der Urologe
2018;57:463-73.
https://doi.org/10.1007/s00120-018-0611-9
13) Torricelli FC, Marchini GS, Yamauchi FI, Danilovic A,
Vicentini FC, Srougi M, et al. Impact of renal anatomy on
shock wave lithotripsy outcomes for lower pole kidney stones:
results of a prospective multifactorial analysis controlled by
computerized tomography. J Urol 2015;193:2002-7.
https://doi.org/10.1016/j.juro.2014.12.026
14) Cui HW, Silva MD, Mills AW, North BV, Turney BW.
Predicting shockwave lithotripsy outcome for urolithiasis
using clinical and stone computed tomography texture
analysis variables. Sci Rep 2019;9:14674.
https://doi.org/10.1038/s41598-019-51026-x
15) Caballer V, Vivas D, Reyes F, Budia A. Cost Effectiveness
Of Extracorporeal Shock Wave Lithotripsy Against
Ureteroscopic Laser Lithotripsy For Treatment of Ureteral
Calculi. Value Health 2014;17:A469.
https://doi.org/10.1016/j.jval.2014.08.1327
16) Zhang Y, Wu Y, Li J, Zhang G. Comparison of percutaneous
nephrolithotomy and retrograde intrarenal surgery for the
treatment of lower calyceal calculi of 2-3 cm in patients with
solitary kidney. Urology 2018;115:65-70.
https://doi.org/10.1016/j.urology.2017.11.063
17) Bozkurt OF, Resorlu B, Yildiz Y, Can CE, Unsal A.
Retrograde intrarenal surgery versus percutaneous
nephrolithotomy in the management of lower-pole
renal stones with a diameter of 15 to 20 mm. J Endourol
2011;25:1131-5.
https://doi.org/10.1089/end.2010.0737
18) Parikh KP, Jain RJ, Kandarp AP. Is retrograde intrarenal
surgery the game changer in the management of upper tract
calculi? A single-center single-surgeon experience of 131
cases. Urol Ann 2018;10:29–34.
https://doi.org/10.1089/end.2010.0737
19) Kandemir A, Guven S, Balasar M, Sonmez MG, Taskapu
H, Gurbuz R. A prospective randomized comparison of
micropercutaneous nephrolithotomy (Microperc) and
retrograde intrarenal surgery (RIRS) for the management of
lower pole kidney stones. World J Urol 2017;35:1771-6.
https://doi.org/10.1007/s00345-017-2058-9
2) ] Demirbas A, Resorlu B, Sunay MM, Karakan T, Karagöz
MA, Doluoglu OG. Which should be preferred for
moderate-size kidney stones? Ultramini percutaneous
nephrolithotomy or retrograde intrarenal surgery? J
Endourol 2016;30:1285-9.
https://doi.org/10.1089/end.2016.0370
21) Xun Y, Wang Q, Hu H, Lu Y, Zhang J, Qin B et al. Tubeless
versus standard percutaneous nephrolithotomy: An update
meta-analysis. BMC Urol 2017;17:102.
https://doi.org/10.1186/s12894-017-0295-2
22) Perez-Ardavin J, Lorenzo L, Caballer-Tarazona V, Budía-
Alba A, Vivas-Consuelo D, Bahilo-Mateu P, et al.
Comparative analysis of direct and indirect costs of two
minimally invasive techniques for the treatment of renal/
ureteral calculi smaller than 2 cm. Actas Urol Esp (Engl Ed)
2020;44:505-11.
https://doi.org/10.1016/j.acuro.2020.03.008
23) Mhaske S, Singh M, Mulay A, Kankalia S, Satav V, Sabale
V. Miniaturized percutaneous nephrolithotomy versus
retrograde intrarenal surgery in the treatment of renal stones
with a diameter ≤15 mm: A 3-year open-label prospective
study. Urol Ann 2018;10:165-9.
https://doi.org/10.4103/UA.UA_156_17